The bizarre pharmacology of the ATP release channel pannexin1
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Pannexins were originally thought to represent a second and redundant family of gap junction proteins in addition to the well characterized coonexins. However, it is now evident that pannexins function as unapposed membrane channels and the major role of Panx1 is that of an ATP release channel. Despite the contrasting functional roles, connexins, innexins and pannexins share pharmacological properties. Most gap junction blockers also attenuate the function of Panx1, including carbenoxolone, mefloquine and flufenamic acid. However, in contrast to connexin based gap junction channels, Panx1 channel activity can be attenuated by several groups of drugs hitherto considered very specific for other proteins. The drugs affecting Panx1 channels include several transport inhibitors, chloride channel blockers, mitochondrial inhibitors, P2X7 receptor ligands, inflammasome inhibitors and malaria drugs. These observations indicate that Panx1 may play an extended role in a wider spectrum of physiological functions. Alternatively, Panx1 may share structural domains with other proteins, not readily revealed by sequence alignments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432 · cited 1×
“Until recently, (see (Abou-Sleiman et al., 2006; Crompton, 1999; Halestrap et al., 2002) for reviews) the main components of the mPTP were considered to be represented by the ADP/ATP translocase and VDAC.”
BackgroundPannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Chekeni, F. B., Elliott, M. R., Sandilos, J. K., Walk, S. F., Kinchen, J. M., Lazarowski, E. R., Armstrong, A. J., Penuela, S., Laird, D. W., Salvesen, G. S., et al. (2010) · Nature · doi:10.1038/nature09413 · Cited by 1,120
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · cited 1×
“Until recently, (see (Abou-Sleiman et al., 2006; Crompton, 1999; Halestrap et al., 2002) for reviews) the main components of the mPTP were considered to be represented by the ADP/ATP translocase and VDAC.”
BackgroundGlyburide inhibits the Cryopyrin/Nalp3 inflammasome
Lamkanfi, M., Mueller, J. L., Vitari, A. C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W. P., Hoffman, H. M., & Dixit, V. M. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903124 · Cited by 820 · cited 2×
“Recently it has been found that glibenclamide also affects innate immunity by inhibiting the inflammasome (Hamon et al., 1997; Lamkanfi et al., 2009; Marty et al., 2005; Muhl et al., 2003).”
Backgroundp53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740
The permeability transition pore complex: another view
Halestrap, A. P., McStay, G. P., & Clarke, S. J. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01375-5 · Cited by 709 · cited 1×
“Until recently, (see (Abou-Sleiman et al., 2006; Crompton, 1999; Halestrap et al., 2002) for reviews) the main components of the mPTP were considered to be represented by the ADP/ATP translocase and VDAC.”
BackgroundPotent block of Cx36 and Cx50 gap junction channels by mefloquine
Cruikshank, S. J., Hopperstad, M., Younger, M., Connors, B. W., Spray, D. C., & Srinivas, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402044101 · Cited by 350
Marty, V., Médina, C., Combe, C., Parnet, P., & Amédée, T. (2005) · Glia · doi:10.1002/glia.20138 · Cited by 41 · cited 2×
“Recently it has been found that glibenclamide also affects innate immunity by inhibiting the inflammasome (Hamon et al., 1997; Lamkanfi et al., 2009; Marty et al., 2005; Muhl et al., 2003).”
Background
Cited by
Emerging importance of satellite glia in nervous system function and dysfunction
Hanani, M., & Spray, D. C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0333-z · Cited by 388
ATP release through pannexon channels
Dahl, G. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0191 · Cited by 258
Self-citationIndependent origins of neurons and synapses: insights from ctenophores
Moroz, L. L., & Kohn, A. B. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0041 · Cited by 171
Glial Connexins and Pannexins in the Healthy and Diseased Brain
Giaume, C., Naus, C. C., Sáez, J. C., & Leybaert, L. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2018 · Cited by 154
Neural versus alternative integrative systems: molecular insights into origins of neurotransmitters
Moroz, L. L., Romanova, D. Y., & Kohn, A. B. (2021) · Philosophical Transactions of the Royal Society B · doi:10.1098/rstb.2019.0762 · Cited by 130
Metadata
- Authors
- Dahl, G., Qiu, F., & Wang, J.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 75
- Pages
- 583-593
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1999673165
- Cited by
- 128
- References
- 8
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The bizarre pharmacology of the ATP release channel pannexin1. https://app.cochat.ai/papers/10.1016/j.neuropharm.2013.02.019
- The paper
- Dahl, G., Qiu, F., & Wang, J. (2013). The bizarre pharmacology of the ATP release channel pannexin1. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2013.02.019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.